Fundación Grupo Efecto Positivo Opposition, Remdesivir, (Wo2016069826 (A1))
No Annotations
Alert me when there are new annotations for this document
1 similar patent oppositions
-
Fundación Grupo Efecto Positivo opposition, Molnupiravir (MK-4482), (AR12285A1)
Countries: Argentina Date: 2022